Our company‘s mission is to provide new treatment options for diseases with high unmet
medical need.
We are committed to innovation and to translating ideas from basic research
into novel drugs. We are also dedicated to fostering collaborations with excellent academic
groups and start-ups. In order to further pool expertise and to join forces with scientists,
Bayer Schering Pharma AG intends to support collaborative research projects on attractive
molecular targets in the fields of
oncology • cardiology • gynecology • in vivo imaging.
Grants are meant to be provided to support research on promising targets. So if you have
discovered a novel molecular drug target and want to develop it further in cooperation with us,
please send us your proposal via our website link (www.grants4targets.com). This website
contains additional information and the terms and conditions that apply to grant allocation.
The deadlines for applications are June 30, 2009, and September 30, 2009.